L

Lord Patel (CB)

Speaking in the House of Lords on 3 June 2026

Debate

Alzheimer’s Disease: Diagnosis and Access to Experimental Drugs

Contribution

I suggest that the Minister looks again at the evidence produced recently by Novo Nordisk, the manufacturer of Wegovy drugs for obesity reduction, to see whether what was just said still applies in the new study.

More from Lord Patel (CB)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

Partner sites